Company: OCEA
Filing Date: 2025-01-13
Form Type: 10-Q
Source: 0001493152-25-001880
Chunk: 5

Company: Ocean Biomedical, Inc.
Filing Date: 2025-01-13
Form: 10-Q
Item: Item 1
Chunk 5
---
 (97,610)

    Effect of Business Combination, including Backstop Agreement, net of redeemed public shares 
     7,654,035  
     -  
     52,070  
     -  
     52,070 
  
    Backstop Agreement Prepayment 
     -  
     -  
     (51,606) 
     -  
     (51,606)
  
    Proceeds from Backstop Agreement 
     -  
     -  
     1,444  
     -  
     1,444 
  
    Issuance of common stock pursuant to the Subscription Agreement 
     1,350,000  
     -  
     14,260  
     -  
     14,260 
  
    Issuance of common stock for extension of loan shares to related party 
     1,365,000  
     -  
     13,595  
     -  
     13,595 
  
    Issuance of common stock related to short-term loans 
     274,477  
     -  
     1,595  
     -  
     1,595 
  
    Shares issued in consideration pursuant to the Marketing Services Agreement 
     13,257  
     -  
     83  
     -  
     83 
  
    Shares issued in consideration pursuant to the Common Stock Purchase Agreement 
     75,000  
     -  
     494  
     -  
     494 
  
    Stock-based compensation 
     -  
     -  
     1,018  
     -  
     1,018 
  
    Offering costs 
     -  
     -  
     (2,049) 
     -  
     (2,049)
  
    Issuances of warrants 
     -  
     -  
     2,301  
     -  
     2,301 
  
    Balances at September 30, 2023 
     34,087,201  
    $-  
    $103,975  
    $(179,199) 
    $(75,224)
  
    Balance 
     34,087,201